HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seiji Shioda Selected Research

Pituitary Adenylate Cyclase-Activating Polypeptide Receptors

11/2014Comparison of expression and proliferative effect of pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptors on human astrocytoma cell lines.
1/2013Expression and distribution of pituitary adenylate cyclase-activating polypeptide receptor in reactive astrocytes induced by global brain ischemia in mice.
11/2012IL-6 and PACAP receptor expression and localization after global brain ischemia in mice.
1/2011Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates proliferation of reactive astrocytes in vitro.
7/2006Pleiotropic functions of PACAP in the CNS: neuroprotection and neurodevelopment.
4/2004[Prevention of delayed neuronal cell death by PACAP and its molecular mechanism].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Seiji Shioda Research Topics

Disease

23Ischemia
06/2016 - 06/2002
14Body Weight (Weight, Body)
01/2019 - 09/2005
11Brain Ischemia (Cerebral Ischemia)
01/2021 - 01/2002
11AIDS-Related Complex (ARC)
04/2010 - 10/2002
9Traumatic Brain Injuries (Traumatic Brain Injury)
01/2019 - 09/2005
9Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
03/2015 - 03/2003
8Inflammation (Inflammations)
01/2022 - 08/2002
7Neoplasms (Cancer)
11/2021 - 11/2003
7Obesity
01/2018 - 05/2008
6Insulin Resistance
01/2018 - 05/2003
6Brain Injuries (Brain Injury)
06/2016 - 01/2002
6Wounds and Injuries (Trauma)
10/2015 - 04/2004
6Infarction (Infarctions)
01/2015 - 03/2003
5Stroke (Strokes)
01/2020 - 05/2007
4Spinal Cord Injuries (Spinal Cord Injury)
02/2015 - 04/2012
3Dry Eye Syndromes (Dry Eye Syndrome)
01/2022 - 01/2016
3Atherosclerosis
01/2022 - 08/2009
3Alzheimer Disease (Alzheimer's Disease)
01/2020 - 08/2012
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020 - 12/2002
3Narcolepsy
01/2019 - 04/2005
3Hypertrophy
01/2018 - 01/2004
3Hyperglycemia
12/2017 - 01/2017
3Neurodevelopmental Disorders
04/2015 - 03/2005
3Ganglion Cysts (Ganglion)
10/2013 - 07/2006
2Glucose Intolerance
01/2022 - 04/2020
2Mental Disorders (Mental Disorder)
11/2021 - 10/2012
2Necrosis
11/2021 - 10/2011
2Asthma (Bronchial Asthma)
11/2020 - 10/2018
2Fatty Liver
04/2020 - 11/2016
2Sleep Wake Disorders
01/2019 - 01/2016
2Neoplasm Metastasis (Metastasis)
01/2017 - 07/2014
2Weight Loss (Weight Reduction)
01/2017 - 07/2004
2Parkinson Disease (Parkinson's Disease)
03/2015 - 12/2013
2Ischemic Stroke
03/2015 - 11/2006
2Pain (Aches)
02/2015 - 10/2003
2Hypoxia (Hypoxemia)
02/2013 - 01/2012
2Contusions
11/2012 - 07/2010
2Central Nervous System Diseases (CNS Diseases)
04/2012 - 03/2005
2Cerebral Infarction
03/2012 - 01/2002
2Optic Nerve Injuries
01/2012 - 11/2008
2Rheumatoid Arthritis
10/2011 - 03/2007
2Cardiovascular Diseases (Cardiovascular Disease)
06/2011 - 12/2006
2Arthritis (Polyarthritis)
03/2010 - 03/2007
2T-Cell Leukemia (Leukemia, T Cell)
03/2010 - 03/2007

Drug/Important Bio-Agent (IBA)

41Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA
01/2022 - 08/2002
14OrexinsIBA
01/2019 - 04/2003
11Peptides (Polypeptides)IBA
01/2020 - 05/2003
10NeuropeptidesIBA
01/2022 - 04/2005
10Messenger RNA (mRNA)IBA
01/2013 - 10/2002
8Glucose (Dextrose)FDA LinkGeneric
01/2022 - 03/2004
8DNA (Deoxyribonucleic Acid)IBA
11/2021 - 11/2003
8Proteins (Proteins, Gene)FDA Link
01/2021 - 11/2002
8LeptinIBA
01/2017 - 05/2003
8Neuroprotective AgentsIBA
10/2015 - 08/2002
6Galanin-Like PeptideIBA
01/2018 - 03/2005
6Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA
11/2014 - 04/2004
5EdaravoneIBA
01/2013 - 01/2002
5Pro-Opiomelanocortin (Proopiomelanocortin)IBA
07/2010 - 05/2003
5Neuropeptide YIBA
06/2005 - 05/2003
4Pharmaceutical PreparationsIBA
01/2020 - 01/2002
4LipidsIBA
10/2018 - 11/2016
4Therapeutic UsesIBA
01/2018 - 02/2009
4Interleukin-1 (Interleukin 1)IBA
12/2013 - 06/2002
4Interleukin-6 (Interleukin 6)IBA
11/2012 - 04/2004
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2010 - 09/2004
3NucleoproteinsIBA
11/2021 - 03/2010
3Insulin (Novolin)FDA Link
01/2017 - 05/2003
3Saline SolutionIBA
01/2015 - 11/2012
3AntioxidantsIBA
11/2014 - 02/2007
3Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
07/2013 - 11/2002
3Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2010 - 01/2002
3Dihydrotachysterol (AT 10)IBA
07/2010 - 01/2008
3GhrelinIBA
01/2008 - 09/2003
3Cytochromes c (Cytochrome c)IBA
08/2007 - 05/2006
2Apolipoproteins E (ApoE)IBA
01/2022 - 11/2014
2Streptozocin (Streptozotocin)FDA Link
01/2022 - 01/2017
2Type I Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA
11/2020 - 09/2005
2Nerve Growth Factors (Neurotrophins)IBA
01/2020 - 12/2002
2AdiponectinIBA
01/2018 - 05/2014
2Neurotransmitter Agents (Neurotransmitter)IBA
01/2017 - 10/2003
2Bromodeoxyuridine (BrdU)IBA
06/2016 - 04/2015
2NADPH Oxidases (NAD(P)H oxidase)IBA
11/2014 - 07/2010
2Reactive Oxygen Species (Oxygen Radicals)IBA
11/2014 - 11/2006
2Superoxides (Superoxide)IBA
11/2014 - 07/2010
2Leptin ReceptorsIBA
11/2014 - 04/2003
2Glial Fibrillary Acidic ProteinIBA
01/2013 - 10/2008
2salicylhydroxamic acid (SHAM)IBA
11/2012 - 07/2009
2Electron Transport Complex IV (Cytochrome c Oxidase)IBA
10/2012 - 08/2007
2CytokinesIBA
04/2012 - 07/2005
2Oxygen (Dioxygen)IBA
03/2012 - 01/2002
2Retinaldehyde (Retinal)IBA
01/2012 - 01/2011
2Peroxynitrous Acid (Peroxynitrite)IBA
07/2010 - 03/2003
2Hormones (Hormone)IBA
08/2009 - 05/2003
2Free RadicalsIBA
05/2008 - 01/2002
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
12/2006 - 11/2004

Therapy/Procedure

4Aftercare (After-Treatment)
10/2011 - 09/2005
2Induced Hypothermia
01/2020 - 01/2013
2Therapeutics
01/2020 - 01/2013
2Intranasal Administration
01/2017 - 01/2016
2Lasers (Laser)
11/2012 - 01/2010